NASDAQ:VRAY - Viewray Stock Price, Forecast & News

Viewray trades on the NASDAQ under the ticker symbol "VRAY."

Viewray Inc (NASDAQ:VRAY) released its earnings results on Tuesday, November, 12th. The company reported ($0.21) EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.06. The firm had revenue of $20.90 million for the quarter, compared to analysts' expectations of $20.66 million. Viewray had a negative return on equity of 75.41% and a negative net margin of 110.61%. The company's quarterly revenue was up 18.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.39) earnings per share. View Viewray's Earnings History.

Viewray is scheduled to release their next quarterly earnings announcement on Thursday, March 12th 2020. View Earnings Estimates for Viewray.

Viewray updated its fourth quarter 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $17-17 million, compared to the consensus revenue estimate of $18.27 million.

9 equities research analysts have issued 1-year price objectives for Viewray's shares. Their forecasts range from $5.00 to $9.00. On average, they anticipate Viewray's stock price to reach $6.44 in the next twelve months. This suggests a possible upside of 109.2% from the stock's current price. View Analyst Price Targets for Viewray.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viewray in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Viewray.

Press coverage about VRAY stock has trended positive recently, InfoTrie reports. The research firm identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Viewray earned a coverage optimism score of 2.6 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Viewray.

Some companies that are related to Viewray include Natus Medical (NTUS), AxoGen (AXGN), TransMedics Group (TMDX), Cutera (CUTR), Stereotaxis (STXS), Zynex (ZYXI), Semler Scientific (SMLR), BioLife Solutions (BLFS), Rockwell Medical (RMTI), Soleno Therapeutics (SLNO), Fonar (FONR), BioSig Technologies (BSGM), Edap Tms (EDAP), Second Sight Medical Products (EYES) and Fc Global Realty (FCRE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Viewray investors own include Alibaba Group (BABA), Cara Therapeutics (CARA), Corbus Pharmaceuticals (CRBP), Sorrento Therapeutics (SRNE), Amarin (AMRN), Amicus Therapeutics (FOLD), Iovance Biotherapeutics (IOVA), Progenics Pharmaceuticals (PGNX), Pieris Pharmaceuticals (PIRS) and Sarepta Therapeutics (SRPT).

(VRAY) raised $52 million in an IPO on the week of April 6th 2015. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Cowen and Company and Stifel served as the underwriters for the IPO and BTIG and Brean Capital were co-managers.

Viewray's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Rhenman & Partners Asset Management AB (0.75%), Kahn Brothers Group Inc. DE (0.54%), Pennsylvania Trust Co (0.13%), California Public Employees Retirement System (0.13%), Joel Isaacson & Co. LLC (0.11%) and Alpine Global Management LLC (0.08%). Company insiders that own Viewray stock include Fmr Llc, International Ltd Fosun, James F Dempsey, Orbimed Advisors Llc, Scott William Drake and Shahriar Matin. View Institutional Ownership Trends for Viewray.

VRAY stock was purchased by a variety of institutional investors in the last quarter, including Kahn Brothers Group Inc. DE, California Public Employees Retirement System, Rhenman & Partners Asset Management AB, Joel Isaacson & Co. LLC, Alpine Global Management LLC, Falcon Point Capital LLC and Pennsylvania Trust Co. Company insiders that have bought Viewray stock in the last two years include International Ltd Fosun, Scott William Drake and Shahriar Matin. View Insider Buying and Selling for Viewray.

Shares of VRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of VRAY stock can currently be purchased for approximately $3.08.

Viewray has a market capitalization of $306.18 million and generates $80.96 million in revenue each year. The company earns $-76,400,000.00 in net income (profit) each year or ($0.98) on an earnings per share basis. View Additional Information About Viewray.

The official website for Viewray is http://www.viewray.com/.

Viewray's mailing address is 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH, 44146. The company can be reached via phone at 440-703-3210 or via email at [email protected]